Cargando…
A fixed-dose randomized controlled trial of olanzapine for psychosis in Parkinson disease
Background: Psychosis is a common and debilitating side effect of long-term dopaminergic treatment of Parkinson disease (PD). While clozapine is an effective treatment, the need for blood monitoring has limited its first-line use. Objective: Since olanzapine shows similar receptor affinity to cloza...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
F1000Research
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3907164/ https://www.ncbi.nlm.nih.gov/pubmed/24627787 http://dx.doi.org/10.12688/f1000research.2-150.v1 |